Glenmark To Conduct Clinical Trials For COVID-19 Drug; Shares Surge
Glemark said the approval made it the first pharmaceutical company in India to be given the go-ahead to start trials on COVID-19 patients.
Keep The Best In Your Boundary
Keep The Best In Your Boundary
Glemark said the approval made it the first pharmaceutical company in India to be given the go-ahead to start trials on COVID-19 patients.